2016
DOI: 10.1016/j.kint.2015.12.043
|View full text |Cite
|
Sign up to set email alerts
|

Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation

Abstract: Scavenger receptor CD36 participates in lipid metabolism and inflammatory pathways important for cardiovascular disease and chronic kidney disease (CKD). Few pharmacological agents are available to slow the progression of CKD. However, apolipoprotein AI-mimetic peptide 5A antagonizes CD36 in vitro. To test the efficacy of 5A, and to test the role of CD36 during CKD, we compared wild type to CD36 knockout mice and wild type mice treated with 5A, in a progressive CKD model that resembles human disease. Knockout … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
47
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 64 publications
(49 citation statements)
references
References 53 publications
1
47
0
1
Order By: Relevance
“…Previous studies in cultured proximal tubule epithelial cells (PTECs) showed that CD36 activation leads to oxidative stress, apoptosis, and pro-fibrotic signalling (fibronectin expression, TGF-β release) [4446]. Similarly, mice deficient in CD36 are resistant to renal fibrosis and oxidative stress in unilateral ureteral obstruction [46,47]. Our data also support a role for CD36 in PTEC fibrogenesis through the stimulation of p38 MAPK and TGF-β receptor-mediated activation of Smad3, collagen type IV and fibronectin.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies in cultured proximal tubule epithelial cells (PTECs) showed that CD36 activation leads to oxidative stress, apoptosis, and pro-fibrotic signalling (fibronectin expression, TGF-β release) [4446]. Similarly, mice deficient in CD36 are resistant to renal fibrosis and oxidative stress in unilateral ureteral obstruction [46,47]. Our data also support a role for CD36 in PTEC fibrogenesis through the stimulation of p38 MAPK and TGF-β receptor-mediated activation of Smad3, collagen type IV and fibronectin.…”
Section: Discussionmentioning
confidence: 99%
“…A study by Okamura et al (26) showed a protective role for CD36 deletion in renal fibrogenesis induced by unilateral ureteral obstruction, through attenuating the proinflammatory pathway. A novel peptide that antagonizes CD36 was recently reported to ameliorate renal inflammation and tubulointerstitial fibrosis, and slow the progression of CKD in the mouse model of unilateral ureteral obstruction and 5/6 nephrectomy (46). Despite this body of evidence, key questions about CD36 as a fatty acid transporter involved in the development of obesity-related CKD are unanswered.…”
Section: Discussionmentioning
confidence: 99%
“…These observations suggest that CD36 is indiscriminate in its binding of LCFA, similar to albumin or the intracellular fatty acid‐binding protein (Schumann & Fuhrmann, ). Souza et al () reported that CD36 seems to play a role in progression of renal disease by causing dyslipidemia in experimental chronic kidney disease.…”
Section: Discussionmentioning
confidence: 99%